APAC Precision Medicine Market size to reach $24 Bn by 2027

Published Date: 2021-09-27

Request a sample

APAC Precision Medicine Market size is poised to cross USD 24 billion by 2027, according to a latest forecast report by Graphical Research.

Precision medicine forums come in a place for supreme networking that facilitates innovative information and idea-sharing regarding patient-specific medicines. Increasing use of online collaborative forums by physicians, biologists, patient groups, governments, and more coupled with unrivaled learning and networking environment will propel the industry size. Precision medicine forum provides an exclusive environment to make new connections, formulate partnerships for future collaboration, and share ideas. Increasing use of the platform for building brand presence, generating new business leads with the leading organizations, reaching global networking groups, and keeping abreast of all the latest news will fuel the business growth.

Asia Pacific precision medicine, based on product segment include therapeutics as well as diagnostics. The therapeutics segment is projected to garner lucrative revenue share and accounted for more than USD 5.8 billion market size in 2020. Therapeutics segment includes all the life-saving drugs that are used in the precision medicine approach for the treatment of diseases such as cancer, neurological disorders, immunological disorders, respiratory disorders and few others. In addition, continuous development in the personalized therapeutics for the targeted treatment of conditions including cancer and genetic disorders will foster the segmental expansion.

Browse detailed statistical insights from the report, “Asia Pacific Precision Medicine Market Forecast 2027 By Product Type (Diagnostics {Genetic Tests, Biomarker Based Tests}, Therapeutics), By Application (Oncology, CNS, Immunology, Respiratory), By End-use (Hospitals, Diagnostic Centers, Research & Academic Institutes), Research Report, Country Outlook (China, Japan, India, South Korea, Australia, Singapore, Taiwan, Hong Kong, Indonesia), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @


Based on application, the precision medicine business is diverged into CNS, respiratory oncology and immunology among others. The respiratory segment accounted for over USD 700 million market size in 2020. Respiratory diseases such as chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, among others are associated with significant morbidity and mortality. In the last few years, precision medicine has gained popularity as an innovative approach that uses novel technology to personalize treatments as per the patient's specific medical needs. Hence, such aspects prove beneficial for the overall segmental progression.

Based on end-use, the precision medicine market is classified into hospitals, research & academic institutes and diagnostic centers among others. The hospital segment accounted for more than 44% revenue share in 2020. Due to rising prevalence of several diseases, patient need proper treatment under the supervision of physicians that increases the patient hospital visits. Similarly, better infrastructure and enhanced quality care provided in hospitals will foster the segmental growth.  

The Japan precision medicine market is anticipated to exhibit more than 11.5% CAGR over the forecast analysis. Japan is at the forefront of research on personalized medication along with various government supported programs such as The BioBank Japan Project. In addition, rising awareness level regarding the significance of precision medicine for superior patient care is further anticipated to propel the country-level expansion, thereby fostering the market growth.

APAC precision medicine market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:

Asia Pacific Market, By Product

  • Diagnostics
    • Genetic tests
    • Biomarker based tests
    • Others
  • Therapeutics

Asia Pacific Market, By Application

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Others

Asia Pacific Market, By End-use

  • Hospitals
  • Diagnostic centers
  • Research & academic institutes
  • Others

The above information has been provided for the following countries:

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Singapore
    • Taiwan
    • Hong Kong
    • Indonesia